Medicine and Dentistry
Antivirus Agent
100%
Proteinase
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Infection
71%
Human Immunodeficiency Virus Fusion Inhibitor
57%
Lipopeptide
57%
Severe Acute Respiratory Syndrome
42%
Virus Infection
28%
In Vitro
28%
Amino Acid
28%
Parainfluenza
28%
Human Immunodeficiency Virus
14%
Bioavailability
14%
Carboxy Terminal Sequence
14%
Measles Virus
14%
Host Cell
14%
Biodistribution
14%
Virus Entry
14%
Protein Degradation
14%
Virus Envelope
14%
Membrane Fusion
14%
Protein Refolding
14%
Virus Attachment
14%
Immune Response
14%
Coronavirinae
14%
Receptor Binding
14%
Cell Membrane
14%
Glycoprotein
14%
Antiviral Drug
14%
Virus
14%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Peptides
100%
Vertebral Column
44%
Severe Acute Respiratory Syndrome
33%
Airway
33%
Viral Disease
22%
Parainfluenza
22%
Amino Acid
22%
Viral Envelope
11%
Viral Entry
11%
Influenza
11%
Receptor Binding
11%
Virus Attachment
11%
Cell Membrane
11%
Membrane Fusion
11%
Mustela Putorius Furo
11%
Human Immunodeficiency Virus
11%
Coronavirinae
11%
Protein Refolding
11%
Measles Virus
11%
Host Cell
11%
Carboxy Terminal Sequence
11%
Immune Response
11%
Glycoprotein
11%
Protein Degradation
11%
Virus
11%
Biochemistry, Genetics and Molecular Biology
SARS Coronavirus
100%
Protease
100%
Lipopeptide
57%
Lipid
28%
Amino Acids
28%
Heptad Repeat
14%
Binding Domain
14%
Membrane Fusion
14%
Human Immunodeficiency Virus
14%
Cell Membrane
14%
Virus Attachment
14%
Glycoprotein
14%
Measles Virus
14%
Protein Refolding
14%
Mustela Putorius Furo
14%
Virus Entry
14%
Virus Envelope
14%
Biodistribution
14%
Immune Response
14%
C-Terminus
14%
Coronavirinae
14%
Receptor Binding
14%
Proteolysis
14%